{
    "guideline": {
        "id": "PA166104991",
        "name": "Annotation of DPWG Guideline for abacavir and HLA-B",
        "source": "DPWG",
        "version": 38,
        "url": "https://www.pharmgkb.org/guidelineAnnotation/PA166104991",
        "relatedChemicals": [
            {
                "id": "PA448004",
                "name": "abacavir",
                "symbol": null
            }
        ],
        "relatedGenes": [
            {
                "id": "PA35056",
                "name": "major histocompatibility complex, class I, B",
                "symbol": "HLA-B"
            }
        ],
        "recommendation": true
    },
    "recommendations": [
        {
            "id": "PA166299245",
            "name": "Recommendation PA166299245",
            "population": null,
            "classification": {
                "term": "N/A",
                "termId": "guidelineStrength:981501929"
            },
            "relatedChemicals": [
                {
                    "id": "PA448004",
                    "name": "abacavir",
                    "symbol": null
                }
            ],
            "text": {
                "id": 1452061608,
                "html": "<p>Abacavir is contra-indicated for HLA-B*57:01-positive patients.</p>\n<ol>\n<li>Avoid abacavir.</li>\n</ol>\n"
            },
            "implications": [
                "HLA-B*57:01-positive patients have a strongly increased risk of a hypersensitivity reaction to abacavir. 48% of the HLA-B*57:01-positive patients develop a severe and potentially life-threatening hypersensitivity reaction to abacavir"
            ],
            "lookupKey": {
                "HLA-B": "*57:01 positive"
            },
            "dosingInformation": false,
            "alternateDrugAvailable": true,
            "otherPrescribingGuidance": false,
            "guidanceLevel": "3"
        }
    ],
    "citations": [
        {
            "pmid": "21412232",
            "title": "Pharmacogenetics: from bench to byte--an update of guidelines.",
            "authors": [
                "Swen J J",
                "Nijenhuis M",
                "de Boer A",
                "Grandia L",
                "Maitland-van der Zee A H",
                "Mulder H",
                "Rongen G A P J M",
                "van Schaik R H N",
                "Schalekamp T",
                "Touw D J",
                "van der Weide J",
                "Wilffert B",
                "Deneer V H M",
                "Guchelaar H-J"
            ],
            "journal": "Clinical pharmacology and therapeutics",
            "year": 2011
        }
    ],
    "version": "2024-03-25-16-13"
}